I know this is an issue that doesn't necessarily fit natural to Congress to be funding physician and provider education, but we're talking about next year reports suggesting that 8 of the top 10 drugs on the market are going to be biosimilars.
Senator Murphy discusses the need for funding education on biosimilars amidst rising drug costs.
Share
More from Chris Murphy
We know that Donald Trump has no clear plan to resolve the Iran War, which has now cost the American taxpayer over $45 billion.
I’ve been a vocal critic of Saudi Arabia and the Crown Prince. But, I think it’s important to be here to disagree and be honest and candid about those disagreements.
This is part of a coordinated, deliberate campaign by the Department of Defense to hide the consequences and the true costs of the Iran war.
With Democrats on the verge of regaining control in Washington, it’s imperative that we offer a new approach to our policy in the Gulf that reflects America’s interests.
Other voices in this conversation
